期刊
TRENDS IN CANCER
卷 4, 期 8, 页码 553-566出版社
CELL PRESS
DOI: 10.1016/j.trecan.2018.06.004
关键词
-
类别
资金
- National Institutes of Health [R01CA195077-01A1, R01CA200919-01, 1R01 CA218008-01A1]
- Research Scholar Grant from American Cancer Society [128347-RSG-15-212-01-TBG]
- Elsa U. Pardee Foundationis
Natural killer (NK) cells of the innate immune system are the first line of defense against infectious agents and cancer cells. However, only a few mechanisms that regulate eradication of tumors by NK cells have been identified. In this review, we present an account of epigenetic mechanisms that modulate the ability of NK cells to eradicate cancer cells. To date, several drugs that target epigenetic modifiers have shown clinical efficacy in cancer. Therefore, once a given epigenetic modifier is validated as a regulator of NK cell function, it can be targeted for NK cell-based cancer immunotherapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据